Neurogene Inc. Reports Q2 2026 Financial Results

What Happened Neurogene Inc. announced its financial results for the quarter ended June 30, 2026 in a press release filed as an 8-K on August 11, 2026. The press release is attached to the filing as Exhibit 99.1. On the same date the company also posted and furnished an updated corporate (investor) presentation as Exhibit 99.2. The 8-K was signed by Christine Mikail, President and Chief Financial Officer.

Key Details

• Filing date: August 11, 2026 (Current Report on Form 8-K).
• Period covered: Quarter ended June 30, 2026.
• Exhibits: Press release (Exhibit 99.1) and corporate presentation (Exhibit 99.2) made available with the filing.
• Authorized signatory: Christine Mikail, President & Chief Financial Officer.

Why It Matters The 8-K provides investors with Neurogene’s latest quarterly financial results and an updated investor presentation—key sources for revenue, earnings, cash position and any operational updates or guidance the company discloses. Investors should review the attached press release and presentation for the specific figures and management commentary that could affect the company’s outlook and stock performance.